ImmunoPrecise Antibodies (OTCMKTS:IPATF) Shares Down 4.5% – Time to Sell?

ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF)’s share price dropped 4.5% on Monday . The company traded as low as $1.06 and last traded at $1.07. Approximately 185,724 shares traded hands during trading, an increase of 814% from the average daily volume of 20,327 shares. The stock had previously closed at $1.12.

ImmunoPrecise Antibodies Stock Performance

The business’s fifty day moving average price is $1.27 and its two-hundred day moving average price is $1.67.

About ImmunoPrecise Antibodies

ImmunoPrecise Antibodies Ltd (OTCMKTS:IPATF) is a Canada-based contract research organization specializing in the discovery and development of therapeutic antibodies. The company provides a full suite of preclinical research services, from target validation and lead identification through to humanization and optimization. Its capabilities encompass hybridoma, phage display, single B cell sorting and next-generation sequencing platforms to accelerate antibody candidate selection and characterization.

ImmunoPrecise serves biopharmaceutical and biotechnology partners worldwide, offering customized solutions for projects in immuno-oncology, infectious diseases, autoimmunity and other therapeutic areas.